Vladimir N Kolyadko

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Venous Thromboembolism

Sensitive Detection

Minimally Invasive

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Haixiang Yu, Shekhar Kumar, James W Frederiksen, Vladimir N Kolyadko, George Pitoc, Juliana Layzer, Amy Yan, Rachel Rempel, Samuel J Francis, Sriram Krishnaswamy, Bruce A Sullenger
Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors. Nature communications 15 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Haixiang Yu, Shekhar Kumar, James W Frederiksen, Vladimir N Kolyadko, George Pitoc, Juliana Layzer, Amy Yan, Rachel Rempel, Samuel J Francis, Sriram Krishnaswamy, Bruce A Sullenger
Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors. Nature communications 15 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)